Evaluating Opicapone as Add-on Treatment to Levodopa/DDCI in Patients with Parkinson’s Disease

Evaluating Opicapone as Add-on Treatment to Levodopa/DDCI in Patients with Parkinson’s Disease

Wolfgang H Jost Parkinson-Klinik Ortenau, Wolfach, 77709, GermanyCorrespondence: Wolfgang H Jost, Parkinson-Klinik Ortenau, Kreuzbergstraße 12-16, Wolfach, 77709, Germany, Tel +49 7834 971-212, Fax +49 7834 971-340, Email w.jost@parkinson-klinik.deAbstract: COMT (catechol-O-methyltransferase) inhibi...

Full description

Bibliographic Details
Main Author: Jost WH
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
parkinson’s disease
motor fluctuations
opicapone
entacapone
comt-inhibitor
therapy
Online Access:https://www.dovepress.com/evaluating-opicapone-as-add-on-treatment-to-levodopaddci-in-patients-w-peer-reviewed-fulltext-article-NDT

Internet

https://www.dovepress.com/evaluating-opicapone-as-add-on-treatment-to-levodopaddci-in-patients-w-peer-reviewed-fulltext-article-NDT

Similar Items